Table 1.
All Patients, n=24 | Acute Procedural Success, n=12 | No Acute Procedural Success n=12 | P Value | |
---|---|---|---|---|
Age | 64±10 | 66±11 | 61±10 | 0.33 |
Male, sex (%) | 14 (61) | 9 (75) | 5 (42) | 0.11 |
Paroxysmal pattern of AF (%) | 12 (50) | 6 (50) | 6 (50) | 1.00 |
AF duration (years from diagnosis) | 7.8±5.5 | 9.0±4.3 | 6.5±6.5 | 0.28 |
Previous AF ablation (%) | 15 (63) | 8 (67) | 7 (58) | 0.69 |
No. of previous AF ablations | 1.2±1.1 | 1.4±1.3 | 0.9±0.9 | 0.29 |
No. of failed antiarrhythmic drugs | 1.7±1.0 | 1.5±0.9 | 1.8±1.0 | 0.41 |
CHA2DS2-VaSC score | 1.7±1.0 | 1.8±1.1 | 1.6±1.0 | 0.57 |
LVEF, % | 63±6.9 | 64±5.7 | 61±8.0 | 0.31 |
LA volume on MRI, mL | 76±32 | 79±31 | 73±33 | 0.64 |
Values are n (%) or mean±SD. AF indicates atrial fibrillation; CHA2DS2-VASc, combined stroke risk score: congestive heart failure, hypertension, age ≥65 or 75 years, diabetes, prior stroke/transient ischemic attack, vascular disease, female sex; LA, left atrium; LVEF, left ventricular ejection fraction; and MRI, magnetic resonance imaging.